Wealth Destroyer - Down 96%, page-18

Yea yea sarge you don’t like the positivity on here all week surrounding the Medicxi partnership and doing all you can to throw shade on it, as you detail of course if the Noval drug turns out to be no good they will kick it to the kerb and move on. So what that’s a gimme in any drug partnership deal what you fail to do in your analysis is detail what the positive outcomes will be for Starpharma if the novel drug turns out to be a gamechanger. You don’t do that as you only want to show the negative therefore your opinions on the deal are worthless downramping banter. Imo